These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
311 related items for PubMed ID: 9174245
41. Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease. Agrawal AK, Chaturvedi RK, Shukla S, Seth K, Chauhan S, Ahmad A, Seth PK. J Chem Neuroanat; 2004 Dec; 28(4):253-64. PubMed ID: 15531136 [Abstract] [Full Text] [Related]
42. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host. Bentlage C, Nikkhah G, Cunningham MG, Björklund A. Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186 [Abstract] [Full Text] [Related]
44. Re-initiated growth from mature ventral mesencephalon: an in oculo transplant study of nigrostriatal co-grafts. Strömberg I, Johansson M. Exp Brain Res; 1994 Mar; 101(1):73-85. PubMed ID: 7843304 [Abstract] [Full Text] [Related]
45. Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats. Palmer MR, Granholm AC, van Horne CG, Giardina KE, Freund RK, Moorhead JW, Gerhardt GA. Brain Res; 2001 Jan 26; 890(1):86-99. PubMed ID: 11164771 [Abstract] [Full Text] [Related]
46. Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4/5 on rat fetal nigral explant cultures. Meyer M, Matarredona ER, Seiler RW, Zimmer J, Widmer HR. Neuroscience; 2001 Jan 26; 108(2):273-84. PubMed ID: 11734360 [Abstract] [Full Text] [Related]
47. Spatial and temporal growth factor influences on developing midbrain dopaminergic neurons. Engele J. J Neurosci Res; 1998 Aug 15; 53(4):405-14. PubMed ID: 9710260 [Abstract] [Full Text] [Related]
48. Platelet-derived growth factor receptor expression after neural grafting in a rat model of Parkinson's disease. Ballagi AE, Odin P, Othberg-Cederström A, Smits A, Duan WM, Lindvall O, Funa K. Cell Transplant; 1994 Aug 15; 3(6):453-60. PubMed ID: 7881757 [Abstract] [Full Text] [Related]
49. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor. Krobert K, Lopez-Colberg I, Cunningham LA. Exp Neurol; 1997 Jun 15; 145(2 Pt 1):511-23. PubMed ID: 9217087 [Abstract] [Full Text] [Related]
50. Cellular distribution of the NMDA receptor subunit NMDAR1 in fetal ventral mesencephalon transplants in the dopamine-depleted striatum of a rat. Todaka K, Ishida Y, Hashiguchi H, Nishimori T, Mitsuyama Y. Exp Neurol; 1999 Dec 15; 160(2):394-401. PubMed ID: 10619556 [Abstract] [Full Text] [Related]
51. Development of human fetal ventral mesencephalic grafts in rats with 6-OHDA lesions of the nigrostriatal pathway. Kondoh T, Pundt LL, Low WC. Neurosci Res; 1995 Jan 15; 21(3):223-33. PubMed ID: 7753503 [Abstract] [Full Text] [Related]
55. Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test. Rozas G, Labandeira García JL. Brain Res; 1997 Feb 28; 749(2):188-99. PubMed ID: 9138718 [Abstract] [Full Text] [Related]